Advertisement
Advertisement
CATX
Perspective Therapeutics, Inc.
2.69
USD-0.07
-2.72%
Feb 25, 11:10 UTC -5
Open
Perspective Therapeutics, Inc. Profile
About
Info & Links
CEO
Johan Thijs Spoor
Headquarters
SEATTLE, WA 98121, UNITED STATES
Industry
Sector
Auditor
Assure CPA LLC
Share holders
243
Employees
119
Perspective Therapeutics, Inc. Statistics
Valuation Measures
Market Capitalization2
181.47M
Enterprise Value
-43.28M
Enterprise Value/EBITDA(ttm)
0.78
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
123.28
Price to Book(mrq)
0.58
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-4288.05%
Profit Margin(ttm)
-4356.21%
Return on Equity(ttm)
-27.40%
Return on Invested Capital(ttm)
-50.10%
Return on Assets(ttm)
-23.16%
Income Statement
Revenue(ttm)
1.56M
Revenue Per Share(ttm)
0.02
Gross Profit(ttm)
1.56M
EBITDA(ttm)3
-55.74M
Net Income Available to Common(ttm)
-63.78M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
1.22
52-Week Change
-72.03%
S&P 500 52-Week Change
16.87%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
67.59M
Dividend Yield
0.00%
Float4
65.21M
% Held by Insiders
3.52%
% Held by Institutions
54.66%
Balance Sheet
Total Cash(mrq)
267.85M
Total Cash Per Share(mrq)
3.96
Total Debt(mrq)
1.69M
Total Debt/Equity(mrq)
0.51%
Current Ratio(mrq)
9.60%
Quick Ratio(mrq)
9.60%
Book Value Per Share(mrq)
4.86
Cash Flow
Operating Cash Flow Per Share(ytd)
0.12
Free Cash Flow(ytd)
-31.49M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement